Study of AZD0754 in Participants With Metastatic Prostate Cancer

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06267729
Phase: PHASE1|PHASE2
Trial Summary: The purpose of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate cancer. – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): AstraZeneca
Acronym: APOLLO

Pin It on Pinterest